Sepsis research honoured

Germany - The third Hugo Schottmüller Prize, awarded by the German Sepsis Society (DSG), has been presented to Dr Marc W Merx, of the Rheinisch-Westfälische Technical University (RWTH) Hospital, Aachen, for his paper 'HMG-CoA Reductase Inhibitor Simvastatin Profoundly Improves Survival in a Murine Model of Sepsis', published in the journal Circulation.

Photo: Sepsis research honoured

The DSG reported that Dr Merx and colleagues had described a promising starting point for a new sepsis therapy. They reported that the drug Simvastatin, which lowers blood cholesterol levels, increased the survival rate of mice suffering sepsis. Dr Merx’ work is a starting point for further investigations on a Simvastatin-based therapy for inflammation-related diseases.

Worth 3,000 euros, the DSG’s research prize is funded by SIRS-Lab GmbH.


Read all latest stories

Related articles


News • Antibacterial cellulose

A wound dressing that kills bacteria

In order to combat bacterial wound infections, Empa researchers have developed cellulose membranes equipped with antimicrobial peptides. Initial results show: The skin-friendly membranes made of…


News •

‘Huge progress’ in the ICU

You’ll find Élie Azoulay everywhere during this year’s International Symposium on Intensive Care and Emergency Medicine (ISICEM).


Article •

Sepsis – a Global Medical Emergency

The Global Sepsis Alliance (GSA) is urging healthcare providers, patients and policymakers worldwide to treat sepsis as a medical emergency. “Tens of millions of people die from sepsis each year,…

Related products

Subscribe to Newsletter